Sector pending / Drugs, Drug Proprietaries, and Druggists' SundriesUpdated 2026-05-10 22:07 UTC

FRA/59Z stock hub

FRA/59Z has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/59Zis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.1B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/59Z

In the news

Latest news · FRA/59Z

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E13.7

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC10.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/59Z market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

178

Groups with data

Currency

JPY

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Japan
Country code	DE
Employees	13,061
Employees Change	-14%
Employees Change Percent	-0.11
Enterprise value	EUR 2.4B
Exchange	Frankfurt Stock Exchange
Financial currency	JPY
First seen	2026-05-10
Industry	Drugs, Drug Proprietaries, and Druggists' Sundries
Last refreshed	2026-05-10
Market cap	EUR 3.1B
Price	EUR 15
Price currency	EUR
Rev Per Employee	1,570,395.46x
Sic	5122
Symbol	fra/59Z
Website	https://www.medipal.co.jp

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.31%
EV Earnings	10.46x
EV/EBIT	8.31x
EV/EBITDA	6.12x
EV/Sales	0.12x
P/B ratio	0.72x
P/E ratio	13.67x
P/S ratio	0.15x
PE Ratio10 Y	13.6x
PE Ratio3 Y	12.1x
PE Ratio5 Y	13.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR 1.4B
Gross Profit Growth	2.5%
Gross Profit Growth Q	1.41%
Gross Profit Growth3 Y	5.24%
Gross Profit Growth5 Y	3.5%
Net Income	EUR 225.2M
Net Income Growth	-16.13%
Net Income Growth Q	5.6%
Net Income Growth3 Y	10.84%
Net Income Growth5 Y	9.21%
Pretax Margin	2.05%
Profit Per Employee	EUR 17,241
Roa5y	1.71
ROCE	6.34
Roe5y	6.57
ROIC	10.71
Roic5y	7.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	2.41%
Cagr3y	5.39%
Cagr5y	1.48%
Div CAGR3	3.11%
Div CAGR5	1.36%
EPS Growth	-15.16
EPS Growth Q	7.21
EPS Growth3 Y	31.47
EPS Growth5 Y	10.98
Revenue Growth	3.42x
Revenue Growth Q	3.22x
Revenue Growth3 Y	4.06x
Revenue Growth5 Y	3.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 11B
Cash	EUR 1.5B
Current Assets	EUR 8B
Current Liabilities	EUR 6.4B
Equity	EUR 4.3B
Interest Coverage	4,856.6
Liabilities	EUR 6.7B
Long Term Assets	EUR 3B
Long Term Liabilities	EUR 344.6M
Net Cash	EUR 1.5B
Net Cash By Market Cap	EUR 48.68
Net Cash Growth	10.59%
Net Debt EBITDA	EUR -3.82
Net Debt Equity	EUR -0.35
Tangible Book Value	EUR 3.3B
Tangible Book Value Per Share	EUR 16.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.25
Net Working Capital	EUR 94.6M
Quick ratio	0.98
Working Capital	EUR 1.6B
Working Capital Turnover	EUR 0.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.06%
Dividend Growth	-6.6%
Dividend Growth Years	6%
Dividend per share	EUR 0.36
Dividend Years	7
Dividend Yield	2.38%
Ex Div Date	2026-03-30
Last Dividend	EUR 0.17
Payout Frequency	Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	2.41%
200-day SMA	15
3Y total return	17.05%
50-day SMA	15.38
50-day SMA vs 200-day SMA	50over200
5Y total return	7.63%
All Time High	17.95
All Time High Change	-16.44%
All Time High Date	2021-03-29
All Time Low	11.5
All Time Low Change	30.43%
All Time Low Date	2022-11-04
ATR	0.27
High	15
High52	16.6
High52 Date	2026-02-27
High52ch	-9.64%
Low	14.9
Low52	13.3
Low52 Date	2025-07-07
Low52ch	12.78%
Ma50ch	-2.46%
Price vs 200-day SMA	0.03%
RSI	47.5
RSI Monthly	51.42
RSI Weekly	48.76
Sharpe ratio	0.08x
Sortino ratio	0.34
Total Return	4.44%
Tr YTD	1.15
Tr1m	-3.23%
Tr1w	-1.32%
Tr3m	-3.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 290.2M
Operating Income Growth	-3.73
Operating Income Growth Q	-0.59
Operating Income Growth3 Y	5.02
Operating Income Growth5 Y	6.11
Operating margin	1.41

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	178,381,556%
Shares Insiders	0.18%
Shares Institutions	41.36%
Shares Qo Q	-0.59%
Shares Yo Y	-2.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	0x
Bv Per Share	17.02
Ch1m	-3.23
Ch1w	-1.32
Ch3m	-4.46
Ch3y	8.7
Ch5y	-4.58
Ch6m	5.63
Change	0%
Change From Open	0.67
Close	15
Days Gap	-0.67
Depreciation Amortization	101,449,332.6
Earnings Date	2026-05-14
EBIT	EUR 290.2M
EBITDA	EUR 392M
EPS	EUR 1.09
F Score	2
Fiscal Year End	March
Founded	1,898
Goodwill	66,206,673.7
Graham Number	22.63198
Graham Upside	50.88
Income Tax	EUR 137.2M
Is Primary Listing	0
Last Earnings Date	2026-02-09
Last Report Date	2025-12-31
Lynch Fair Value	EUR 10.11
Lynch Upside	-32.62
Ma150	15.03
Ma150ch	-0.2%
Ma20	14.93
Ma20ch	0.47%
Next Earnings Date	2026-05-14
Open	14.9
Payment Date	2026-06-03
Position In Range	100
Ppne	1,421,922,548.7
Price Date	2026-05-08
Price EBITDA	EUR 7.85
Ptbv Ratio	0.94
Relative Volume	2,000x
Revenue	20,510,935,081x
Tax By Revenue	0.67x
Tr6m	6.85%

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/59Z dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.4%

$0.36 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+1.4%

6 consecutive years of growth

Total shareholder yield

+4.4%

Next ex-dividend date: 2026-03-30

Performance

FRA/59Z stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/59Z?

Insider, institutional, and short-interest positioning.

Institutional ownership

+41.4%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.1%

Negative means the company is buying back shares.

Technical

FRA/59Z momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.5

Neutral momentum band

Price vs 200-day MA

+0.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/59Z

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/59Z stock rating?

fra/59Z is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/59Z analysis?

The full report lives at /stocks/fra/59Z/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/59Z?

The latest report frames fra/59Z around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/59Z page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.